1. Home
  2. COTY vs PCVX Comparison

COTY vs PCVX Comparison

Compare COTY & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coty Inc.

COTY

Coty Inc.

HOLD

Current Price

$3.07

Market Cap

2.9B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$46.23

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COTY
PCVX
Founded
1904
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
6.1B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
COTY
PCVX
Price
$3.07
$46.23
Analyst Decision
Hold
Strong Buy
Analyst Count
18
7
Target Price
$5.34
$101.67
AVG Volume (30 Days)
6.5M
1.5M
Earning Date
02-09-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,798,600,000.00
N/A
Revenue This Year
$1.72
N/A
Revenue Next Year
$2.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.94
$27.66
52 Week High
$7.71
$93.77

Technical Indicators

Market Signals
Indicator
COTY
PCVX
Relative Strength Index (RSI) 35.81 52.46
Support Level $2.94 $42.40
Resistance Level $3.11 $48.65
Average True Range (ATR) 0.10 1.54
MACD -0.01 0.16
Stochastic Oscillator 26.04 64.49

Price Performance

Historical Comparison
COTY
PCVX

About COTY Coty Inc.

Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: